Internal Medicine, Pulmonary Disease · Troy, MI
NPI
1306861414
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
44199 Dequindre Rd, Suite 311
Troy, MI, 48085
Phone (248) 964-9490
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
1,758 services
Medicare patients, 2024
602
Average age 76
Drug cost, 2024
$6.6M
1,213 prescriptions
Company payments, 2025
$43K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samuel A Allen was code 99233 (hospital e&m - subsequent), 430 times for 196 patients. In total Samuel A Allen billed 1,758 services in 33 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 430 | 196 | $93.53 | $40K |
| 99232 Hospital E&M - Subsequent | Facility | 401 | 191 | $62.98 | $25K |
| 99291 Critical Care E&M | Facility | 169 | 99 | $170.55 | $29K |
| 99214 Office E&M - Established | Facility | 132 | 105 | $72.01 | $9,505 |
| 99222 Hospital E&M - Initial | Facility | 80 | 76 | $102.50 | $8,200 |
| 94726 Pulmonary Function Testing | Facility | 67 | 67 | $9.39 | $629 |
| 94618 Pulmonary Function Testing | Facility | 66 | 64 | $17.45 | $1,152 |
| 94729 Pulmonary Function Testing | Facility | 64 | 64 | $7.02 | $449 |
| 94010 Pulmonary Function Testing | Facility | 60 | 60 | $6.39 | $384 |
| 99223 Hospital E&M - Initial | Facility | 51 | 49 | $139.16 | $7,097 |
| 99214 Office E&M - Established | Office | 44 | 38 | $102.84 | $4,525 |
| 31624 Bronchoscopy | Facility | 31 | 31 | $96.70 | $2,998 |
| 99204 Office E&M - New | Facility | 26 | 26 | $92.22 | $2,398 |
| 99215 Office E&M - Established | Facility | 21 | 20 | $112.58 | $2,364 |
| 99213 Office E&M - Established | Office | 14 | 13 | $62.48 | $875 |
By year: 2022 $152K for 1,699 services; 2023 $149K for 1,600 services; 2024 $143K for 1,758 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samuel A Allen prescribed most often to Medicare patients was Opsumit (Macitentan), with 215 prescriptions and refills. In total Samuel A Allen wrote 1,213 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 215 | 215 | 26 | $2.7M |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 182 | 331 | 65 | $200K |
| Tadalafil Generic | 118 | 120 | 14 | $63K |
| Prednisone Generic | 89 | 137 | 49 | $333 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 79 | 121 | 50 | $3,937 |
| Tyvaso Dpi Treprostinil | 62 | 62 | 15 | $1.5M |
| Adempas Riociguat | 42 | 42 | Under 11 | $579K |
| Breo Ellipta Fluticasone/Vilanterol | 32 | 51 | Under 11 | $18K |
| Cefuroxime Cefuroxime Axetil | 27 | 27 | 17 | $298 |
| Montelukast Sodium Generic | 26 | 52 | Under 11 | $384 |
| Letairis Ambrisentan | 24 | 24 | Under 11 | $314K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 23 | 33 | 14 | $1,983 |
| Opsynvi Macitentan/Tadalafil | 21 | 21 | Under 11 | $272K |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 17 | 19 | Under 11 | $13K |
| Ambrisentan Generic | 17 | 17 | Under 11 | $98K |
Brand drugs: 787 claims; generic drugs: 426 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel A Allen $43K ($43K in general payments such as food, travel and fees) from 18 companies. The largest payer was Actelion Pharmaceuticals US, Inc. with $33K.
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. JNJ | 38 | $33K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $7,693 |
| AstraZeneca Pharmaceuticals LP AZN | 23 | $655 |
| Genzyme Corporation SNY | 3 | $348 |
| Verona Pharma, Inc. VRNA | 23 | $313 |
| GlaxoSmithKline, LLC. GSK | 16 | $248 |
| Insmed, Inc. INSM | 12 | $200 |
| Ethicon Inc. JNJ | 4 | $170 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $89.99 |
| Electromed, Inc. ELMD | 5 | $65.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.